Form 4: Cognition Therapeutics CEO Lisa Ricciardi Reports Stock Transactions

CEO Lisa Ricciardi reports acquisition and disposal of Cognition Therapeutics (CGTX) stock, including purchases, tax withholding, and vesting of restricted stock units.

Summary

• Lisa Ricciardi, CEO and President of Cognition Therapeutics Inc. (CGTX), filed a Form 4 detailing changes in beneficial ownership.
• On January 31, 2025, Ricciardi acquired 38,851 shares of common stock at a weighted average price of $0.7722 per share, held indirectly through a spouse.
• On February 3, 2025, 28,960 shares were disposed of to cover tax withholding obligations related to the vesting of restricted stock units (RSUs) at a price of $0.666.
• On February 4, 2025, Ricciardi acquired 631,300 shares represented by RSUs at $0.00.
• Following these transactions, Ricciardi directly owns 893,685 shares and indirectly owns 38,851 shares.
• The filing indicates that a portion of the transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reports routine stock transactions related to executive compensation and tax obligations. There's no clear indication of positive or negative sentiment towards the company's prospects.

Positives

• The CEO's acquisition of 631,300 shares through RSU vesting could be seen as a positive sign of confidence in the company's future.

Negatives

• The disposal of 28,960 shares to cover tax obligations, while routine, represents a reduction in the CEO's direct holdings.

Risks

• The Form 4 filing itself doesn't inherently indicate risks, but the stock transactions could be interpreted in various ways by the market.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The transactions may influence investor perception of the company, but the direct impact on other stakeholders is likely minimal.

Key Dates